Thanks to its interaction with CB1 and CB2 receptors of the endocannabinoid system, CBD is able to combat pain and inflammation, factors that often accompany osteoporosis.
Osteoporosis is a condition that affects the skeletal system, causing a loss of bone mass, mineral density, and strength. Osteoporosis leads to a gradual but relentless deterioration of the skeleton, resulting in a state of bone fragility that exposes the affected individual to a higher risk of fractures. In recent years, the results of several experiments have highlighted how cannabidiol (CBD), the non-psychoactive active ingredient of the cannabis plant, could play a crucial role in the context of therapies adopted to combat osteoporosis.
What is Osteoporosis?
Osteoporosis refers to the loss of mass and subsequent weakening of bones that make up the human skeleton. The disease is progressive and leads to an increased risk of fracture even from minor traumas, particularly affecting the ankles, wrists, vertebrae, femur, and humerus. The disease generally strikes during old age.
The social cost is enormous, considering the general aging of the population and the fact that for many people, the disease can develop asymptomatically.
Moreover, there's a serious problem in quantifying the number of people affected. Osteoporosis can progress unnoticed until the person suffering from it experiences trauma. The first manifestations, in fact, appear with fractures. Localized and continuous pain is a fairly specific symptom of osteoporosis. The medical interest in CBD is also due to its ability to combat pain and inflammation, events or factors that often accompany osteoporosis.